
    
      The Medicines Control Council (MCC) authorities requested that subjects be screened for HIV
      testing prior to study enrolment in South Africa to ensure that only HIV negative
      participants are enrolled. As such, HIV rapid test was added at Visit 1 only for subjects in
      South Africa. Subjects previously screened HIV positive will be excluded.
    
  